Literature DB >> 17054762

Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region.

M Miura1, Y Miura, W Sonoyama, T Yamaza, S Gronthos, S Shi.   

Abstract

The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17054762     DOI: 10.1111/j.1601-0825.2006.01300.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  19 in total

1.  The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects.

Authors:  Václav Vaněček; Karel Klíma; Aleš Kohout; René Foltán; Ondřej Jiroušek; Jiří Šedý; Jan Štulík; Eva Syková; Pavla Jendelová
Journal:  Eur Spine J       Date:  2013-09-07       Impact factor: 3.134

2.  Expansion and characterization of human embryonic stem cell-derived osteoblast-like cells.

Authors:  Premjit Arpornmaeklong; Zhuo Wang; Michael J Pressler; Shelley E Brown; Paul H Krebsbach
Journal:  Cell Reprogram       Date:  2010-08       Impact factor: 1.987

3.  In vivo gene activity of human mesenchymal stem cells after scaffold-mediated local transplantation.

Authors:  Soon Jung Hwang; Tae Hyung Cho; In Sook Kim
Journal:  Tissue Eng Part A       Date:  2014-04-28       Impact factor: 3.845

4.  Culture human mesenchymal stem cells with calcium phosphate cement scaffolds for bone repair.

Authors:  Michael D Weir; Hockin H K Xu
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-04       Impact factor: 3.368

5.  Evaluation of new bone formation in irradiated areas using association of mesenchymal stem cells and total fresh bone marrow mixed with calcium phosphate scaffold.

Authors:  P Bléry; P Corre; O Malard; S Sourice; P Pilet; Y Amouriq; J Guicheux; P Weiss; F Espitalier
Journal:  J Mater Sci Mater Med       Date:  2014-08-01       Impact factor: 3.896

6.  Clinical and surgical management of an aggressive cherubism treated with autogenous bone graft and calcitonin.

Authors:  Mônica Fernandes Gomes; Lilibeth Ferraz de Brito Penna Forte; Cybelle Mori Hiraoka; Flávio Augusto Claro; Mônica Costa Armond
Journal:  ISRN Dent       Date:  2010-10-17

7.  Candidates cell sources to regenerate alveolar bone from oral tissue.

Authors:  Masahiro Nishimura; Kazuma Takase; Fumio Suehiro; Hiroshi Murata
Journal:  Int J Dent       Date:  2012-02-14

8.  Klotho in Osx+-mesenchymal progenitors exerts pro-osteogenic and anti-inflammatory effects during mandibular alveolar bone formation and repair.

Authors:  Yi Fan; Chen Cui; Clifford J Rosen; Tadatoshi Sato; Ruoshi Xu; Peiran Li; Xi Wei; Ruiye Bi; Quan Yuan; Chenchen Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-05-11

Review 9.  Pulp tissue from primary teeth: new source of stem cells.

Authors:  Paloma Dias Telles; Maria Aparecida de Andrade Moreira Machado; Vivien Thiemy Sakai; Jacques Eduardo Nör
Journal:  J Appl Oral Sci       Date:  2011 May-Jun       Impact factor: 2.698

10.  The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.

Authors:  Tatsuki Uchiyama; Hiroshi Kawabata; Yasuo Miura; Satoshi Yoshioka; Masaki Iwasa; Hisayuki Yao; Soichiro Sakamoto; Masakazu Fujimoto; Hironori Haga; Norimitsu Kadowaki; Taira Maekawa; Akifumi Takaori-Kondo
Journal:  Cancer Med       Date:  2015-08-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.